The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Reporting on quality indicators in renal cell carcinoma: Proportion of metastatic patients who initially commence on full-dose targeted therapy.
 
Lori Wood
Research Funding - Bristol-Myers Squibb (Inst); GlaxoSmithKline (Inst); Novartis (Inst)
Travel, Accommodations, Expenses - Novartis
Other Relationship - Astellas Pharma; Janssen Oncology; Pfizer
 
Daniel Yick Chin Heng
No Relationships to Disclose
 
Jennifer J. Knox
No Relationships to Disclose
 
Georg A. Bjarnason
No Relationships to Disclose
 
Christian K. Kollmannsberger
Honoraria - Novartis; Pfizer
 
Anil Kapoor
No Relationships to Disclose
 
Sebastien J. Hotte
Consulting or Advisory Role - Astellas Pharma; Janssen
 
Marie Vanhuyse
No Relationships to Disclose
 
Piotr Czaykowski
No Relationships to Disclose
 
Denis Soulieres
No Relationships to Disclose
 
Antonio Finelli
Stock and Other Ownership Interests - Abbvie; Baxter; Bristol-Myers Squibb; Gilead Sciences; Merck; Novo Nordisk; Pfizer; Sanofi; Teva
Honoraria - Amgen; Astellas Pharma; Janssen Oncology
Consulting or Advisory Role - Amgen; Astellas Pharma; Janssen Oncology
 
Zhihui Liu
No Relationships to Disclose